RETRACTION: miR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung Cancer (Retraction of Vol 14, Pg 4335, 2021)

被引：0
|
作者：
Wang, J.
Wang, L.
Zhang, C.
机构：
来源：
ONCOTARGETS AND THERAPY | 2023年 / 16卷
关键词：
D O I：
10.2147/OTT.S448601
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：937 / 937
页数：1
相关论文
共 50 条
  • [1] RETRACTED: miR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung Cancer (Retracted Article)
    Wang, Jiying
    Wang, Li
    Zhang, Congjun
    ONCOTARGETS AND THERAPY, 2021, 14 : 4335 - 4343
  • [2] RETRACTION: Prognosis and Biological Function of miR-3195 in Non-Small Cell Lung Cancer (Retraction of Vol 14, Pg 169, 2022)
    Lu, Y.
    Zhang, X.
    Zhang, H.
    Zhu, Z.
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 1265 - 1265
  • [3] RETRACTION: CDK14 expression is elevated in patients with non-small cell lung cancer and correlated with poor prognosis (Retraction of Vol 49, art no 3000605211013199, 2021)
    Yang, Y.
    Yuan, G.
    Xie, H.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (06)
  • [4] RETRACTION: CDK14 expression is elevated in patients with non-small cell lung cancer and correlated with poor prognosis
    Yang, Yong
    Yuan, Guangda
    Xie, Hongya
    Wei, Tengteng
    Zhu, Donglin
    Zhu, Yimeng
    Zheng, Shiying
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (10)
  • [5] RETRACTION: NEK2 plays an active role in Tumorigenesis and Tumor Microenvironment in Non-Small Cell Lung Cancer (Retraction of Vol 17, Pg 1995, 2021)
    Bai, Rui
    Yuan, Cheng
    Sun, Wenjie
    Zhang, Jianguo
    Luo, Yuan
    Gao, Yanping
    Li, Yangyi
    Gong, Yan
    Xie, Conghua
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (10): : 3943 - 3943
  • [6] RETRACTION: PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer (Retraction of Vol 8, Pg 1795, 2017)
    Li, Ming
    Zhang, Weiwei
    Zhang, Shenjun
    Wang, Changhui
    Lin, Yinping
    JOURNAL OF CANCER, 2023, 14 (08): : 1335 - 1335
  • [7] RETRACTION: miR-154 suppresses non-small cell lung cancer growth in vitro and in vivo (Retraction of Vol 33, Pg 3053, 2015)
    Lin, Xingyu
    Yang, Zhiguang
    Zhang, Peng
    Shao, Guoguang
    ONCOLOGY REPORTS, 2023, 49 (06)
  • [8] RETRACTION: miR-202 functions as a tumor suppressor in non-small cell lung cancer by targeting STAT3 (Retraction of Vol 16, Pg 2281, 2017)
    Zhao, Zhonghai
    Lv, Bin
    Zhang, Li
    Zhao, Nana
    Lv, Yan
    MOLECULAR MEDICINE REPORTS, 2022, 26 (04)
  • [9] RETRACTION: Overexpression of miR-4286 is an unfavorable prognostic marker in individuals with non-small cell lung cancer (Retraction of Vol 313, Pg 17573, 2019)
    An, Xian
    Ge, Jiwen
    Guo, Huihui
    Mi, Huaixue
    Zhou, Jinhua
    Liu, Yongrui
    Weiyue
    Wu, Zhilian
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2020, 121 (8-9) : 4003 - 4003
  • [10] RETRACTION: miR-592 functions as a tumor suppressor in human non-small cell lung cancer by targeting SOX9 (Retraction of Vol 37, Pg 297, 2017)
    Li, Zhihong
    Li, Bai
    Niu, Liang
    Ge, Liang
    ONCOLOGY REPORTS, 2022, 47 (02)
12345